Multi-Arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate Covid-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial

OA Location

https://doi.org/10.1182/blood-2021-148480

Author(s)

Charania, A Sad

Vergis, Nikhil

Phillips, Rachel

Cornelius, Victoria

Katsarou, Alexia

more

Type

Conference Paper

Date Issued

2021-11-23

Date Acceptance

2021-12-01

Citation

Blood, 2021, 138 (Supplement 1), pp.4200-4200

URI

http://hdl.handle.net/10044/1/104886

URL

https://ashpublications.org/blood/article/138/Supplement%201/4200/481499/Multi-Arm-Trial-of-Inflammatory-Signal-Inhibitors

DOI

https://www.dx.doi.org/10.1182/blood-2021-148480

ISSN

0006-4971

Publisher

American Society of Hematology

Start Page

4200

End Page

4200

Journal / Book Title

Blood

Volume

138

Issue

Supplement 1

Copyright Statement

© 2021 by The American Society of Hematology

Identifier

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000835740100201&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Source

63rd ASH Annual Meeting and Exposition

Subjects

Hematology

Life Sciences & Biomedicine

Science & Technology

Publication Status

Published

Start Date

2021-12-11

Finish Date

2021-12-14

Coverage Spatial

Atlanta, GA

Date Publish Online

2021-12-24